Results for tag: "Premenstrual Dysphoric Disorder"

Premenstrual Dysphoric Disorder (PMDD) is a severe form of premenstrual syndrome (PMS) that affects up to 8% of women of reproductive age. Symptoms of PMDD include depression, anxiety, irritability, mood swings, fatigue, and physical symptoms such as bloating and breast tenderness. Treatment options for PMDD include lifestyle changes, medications, and psychotherapy. The Women's Health market is a rapidly growing sector, with PMDD being a major focus. Companies are developing innovative treatments and therapies to help women manage their symptoms. These treatments range from hormone therapy to cognitive behavioral therapy, and many companies are researching new treatments to improve the quality of life for women with PMDD. Companies in the PMDD market include Allergan, Pfizer, AbbVie, and Eli Lilly. These companies are developing treatments and therapies to help women manage their symptoms and improve their quality of life. Show Less Read more